- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT01093248
Methadone Maintenance Treatment Outcome Study in Taiwan (M0508)
Opioid abuse is a complex problem, which not only impacts on the affected individuals' physical and psychological health, but also threatens public security and the productivity of the society. Further, through needle sharing and sexual contacts, injecting drug users (IDUs) have become laden with HIV and HIV related health problems, representing a serious public health threat all over the world. In Taiwan, since the identification of the first HIV-infected IDU in 1987, the incident cases have continued to increase, reaching a height of 2,461 in 2005. In order to contain the epidemics of HIV among IDUs, and to prevent its spread to the population in general, the Center for Disease Control (CDC) collaborated with the Department of Justice to initiate and implement a number of harm reduction programs in 2005. The fact that opioid addiction is officially treated as a health rather than a legal issue itself represents a remarkable milestone in Taiwan. Among these harm reduction programs, including needle and syringe exchange for IDUs as well as substitution treatment approaches for opioid dependence, methadone maintenance treatment (MMT) perhaps represents the most most important and most crucial component. Remarkably, in a relatively short time span, more than 60 MMT programs were established, which enrolled more than 15,000 heroin addicts. This notwithstanding, the overall and differential effectiveness of these MMT service delivery systems, as well as the characteristics of these programs and the patients that might contribute toward treatment response or failure remain largely unknown. Such knowledge base is crucial for establishing standardized and feasible outcome evaluation processes for opioid addicts receiving MMT programs, as well as for the further improvement of the efficacy and effectiveness of these programs, in Taiwan.
In order to address some of these issues, this study adopts a multi-site, prospective clinical follow-up design. It aims at establishing a research network for examining MMT outcome, developing standardized MMT outcome assessment instruments and procedures, and identifying predictors of MMT outcome. The findings may contribute to the better understanding of the characteristics of opioid addicts, the effectiveness of MMT and remaining service needs for opioid addicts in Taiwan.
Panoramica dello studio
Stato
Condizioni
Tipo di studio
Iscrizione (Anticipato)
Contatti e Sedi
Luoghi di studio
-
-
-
Miaoli, Taiwan
- Reclutamento
- Departments of Psychiatry, Wei-Gong Memorial Hospital
-
Investigatore principale:
- Ming-Lun Liu, MD
-
Contatto:
- Ming-Lun Liu, MD
-
Taichung, Taiwan
- Reclutamento
- Departments of Psychiatry, China Medical University and Hospital
-
Investigatore principale:
- Chieh-Liang Huang, MD
-
Contatto:
- Chieh-Liang Huang, MD
-
Taipei, Taiwan
- Reclutamento
- Departments of Psychiatry, Taipei City Hospital Song-De Campus
-
Investigatore principale:
- Lien-Wen Su, MD
-
Contatto:
- Lien-Wen Su, MD
-
Taipei, Taiwan
- Reclutamento
- Departments of Psychiatry, Taipei City Hospital Yang-Ming Campus
-
Investigatore principale:
- Yih-Hong Yang, MD
-
Sub-investigatore:
- Yung-Chun Fang, MD
-
Contatto:
- Yih-Hong Yang, MD
-
Taipei, Taiwan
- Reclutamento
- Departments of Psychiatry, Far-Eastern Memorial Hospital
-
Investigatore principale:
- Chi-Shin Wu, MD
-
Sub-investigatore:
- Kai-Chi Fang, MD
-
Contatto:
- Chi-Shin Wu, MD
-
Taipei County, Taiwan
- Reclutamento
- Departments of Psychiatry, En-Chu-Kong Hospital
-
Investigatore principale:
- Li-Nen Lin, MD
-
Sub-investigatore:
- Yen-Feng Lin, MD
-
Contatto:
- Li-Nen Lin, MD
-
Tao-Yuan, Taiwan
- Reclutamento
- Departments of Psychiatry, Tao-yuan Psychiatric Center
-
Contatto:
- Happy Kuy-Lok Tan, MD, MPH
-
Investigatore principale:
- Happy Kuy-Lok Tan, MD, MPH
-
Sub-investigatore:
- Sun-Yuan Chou, MD
-
Sub-investigatore:
- Kuen-Hong Wu, MD
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion Criteria:
- Be 18 years or older.
- Be fulfilling the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria of opiate dependence.
- Be agree to and capable of signing informed consent form that has been approved by an Institution Review Board.
Exclusion Criteria:
- Have ever participated in the study at one of the collaborative hospitals/clinics.
- Be expecting to discontinue methadone treatment for any reason (leaving the methadone clinic's geographic area, pending legal action, etc.) in the following 3 months.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Coorti e interventi
Gruppo / Coorte |
---|
Heroin-addicted Patients
Heroin-addicted outpatient department (OPD) patients who seek help for methadone maintenance treatment
|
Collaboratori e investigatori
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Anticipato)
Completamento dello studio (Anticipato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 99A1-PHPP39 (Altro numero di sovvenzione/finanziamento: National Health Research Institutes)
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .